Randomized active and placebo-controlled endoscopy study of a novel protected formulation of oral alendronate

Digestive Diseases and Sciences

Volumn 51, Issue 5, 2006, Pages 864-868

  Marshall, John K ^a   Thabane, Marroon ^a   James, Cindy ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Alendronate; Aminobisphosphonate; Endoscopy; Esophageal erosion; Gastroduodenal erosion; Gastroduodenal ulcers; Upper gastrointestinal toxicity

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; DUODENUM ULCER; ESOPHAGITIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAGET BONE DISEASE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH ULCER; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; ENDOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIC ULCER; TREATMENT OUTCOME;

EID: 33745831938     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9094-4     Document Type: Article

References (9)

1. de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H, Wang KK (1996) Esophagitis associated with the use of alendronate. N Engl J Med 335:1016-1021
2. Marshall JK (2002) The gastrointestinal tolerability and safety of oral bisphosphonates. Expert Opin Drug Saf 1:71-78
3. Marshall JK, Rainsford KD, James C, Hunt RH (2000) A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract. Aliment Pharmacol Ther 14:1451-1457
4. Lanza FL, Hunt RH, Thomson ABR, Provenza JM, Blank MA (2000) Endoscopic comparison of esophageal and gastric effects of risedronate and alendronate in postmenopausal women. Gastroenterology 119:631-638
5. Thomson AB, Marshall JK, Hunt RH, Provenza JM, Lanza FL, Royer MG, Li Z, Blank MA (2002) 14-day endoscopy study comparing risedronate and alendronate in post-menopausal women stratified by Helicobacter pylori status. J Rheumatol 29:1965-1974
6. Lanza FL, Panagides J, Salom IL (1986) Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers. J Rheumatol 13:299-303
7. Lanza FL, Rack MF, Li Z, Krajewski SA, Blank MA (2000)Placebo-controlled randomized evaluator-blinded endoscopy study of risedronate vs. aspirin in healthy post-menopausal women. Aliment Pharmacol Ther 14:1663-1670
8. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG, Grant AK, Shearman DJ, Whitehead R, Buckle PJ (1988) Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95:903-912.
9. Famularo G, De Simone C (2001) Fatal esophageal perforation with alendronate. Am J Gastroenterol 96:3212-3213